Latest torsades de pointes Stories
ALISO VIEJO, Calif., April 11, 2011 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the appointment of William (Bill) Sibold to the position of senior vice president and chief commercial officer. In this newly created role, Mr.
ALISO VIEJO, Calif., April 7, 2011 /PRNewswire/ -- Avanir Pharmaceuticals, Inc.
Long QT syndrome approximately affects one in every 2,500 people Â-mainly young people.
ALISO VIEJO, Calif., Feb. 3, 2011 /PRNewswire/ -- AVANIR Pharmaceuticals, Inc.
KING OF PRUSSIA, Pa., Nov. 18, 2010 /PRNewswire/ -- Prism Pharmaceuticals, Inc. announced today that the U.S.
ALISO VIEJO, Calif., Nov. 1, 2010 /PRNewswire-FirstCall/ -- AVANIR Pharmaceuticals, Inc. (Nasdaq: AVNR) today announced a management conference call to discuss the approval of NUEDEXTA(TM) (dextromethorphan hydrobromide and quinidine sulfate) by the U.S. Food and Drug Administration (FDA).
Drug associated with a life-threatening heart abnormality when used with another antiviral medicine SILVER SPRING, Md., Oct. 21 /PRNewswire-USNewswire/ -- The U.S.
Review of data indicating life-threatening heart abnormality underway SILVER SPRING, Md., Feb. 23 /PRNewswire-USNewswire/ -- The U.S.
By Erdogan, Okan Aksoy, Alper; Turgut, Nilda; Durusoy, Elcim; Samsa, Murat; Altun, Armagan Abstract Andersen-Tawil syndrome (ATS) is a rare, heterogeneous, autosomal dominant, or sporadic disorder characterized by the clinical triad of periodic paralysis, dysmorphic features, and ventricular arrhythmias such as bidirectional ventricular tachycardia (BVT).